Rajaraman Gopalakrishnan

Rajaraman Gopalakrishnan began their work experience as a Summer Student at the Indian Institute of Science in 2011, followed by a role as a Summer Student at Vanderbilt University in 2012. In 2014, they joined Harvard Medical School as a PhD Candidate, where they focused on studying the role of the conserved histone chaperone Spt6 in regulating transcription elongation and histone methylation. During this time, they constructed libraries for whole genome sequencing and developed a bioinformatic pipeline for high-throughput identification of genomic variants. Rajaraman also conducted ChIP-seq experiments and developed a bioinformatic pipeline for quantitative comparison of histone methylation levels between different mutants. In 2019, Rajaraman became a Postdoctoral Scholar at Novartis Institutes for BioMedical Research (NIBR), where they developed a computational pipeline for analyzing ATAC-Seq data and generated stable knockdown cell lines to test hypotheses related to drug resistance. Rajaraman also analyzed ChIP-Seq and HiChIP datasets to compare transcription factor binding and DNA looping across different cancer cell lines. Most recently, Rajaraman joined Alltrna as a Scientist II in 2021.

Rajaraman Gopalakrishnan completed their Bachelor of Technology in Biotechnology at the Indian Institute of Technology, Roorkee from 2009 to 2013. Rajaraman then pursued a Doctor of Philosophy in Genetics and Genomics at Harvard University from 2013 to 2019.